Brawn Biotech Ltd — Important, 08-07-2026: Company Update

Brawn Biotech has submitted a compliance certificate from its Registrar and Share Transfer Agent regarding the processing of dematerialized securities. For the recent quarter, the certificate confirms that securities received for dematerialization were duly processed, accepted or rejected, and listed on stock exchanges. It further assures that physical certificates were cancelled and depository names were updated in the register of members within the stipulated timeframe. This update provides investors with confidence in the proper management of their electronic share records and the company's adherence to standard market practices.